ME/CFS Science @mecfsscience.org · 15/05/20263) The other antibodies tested showed no significant difference between ME/CFS patients and healthy controls. 35% of ME/CFS patients had POTS but this subgroup didn't have different levels of autoantibodies either. 1100
ME/CFS Science @mecfsscience.org · 15/05/20264) The authors highlight correlations between muscaranic autoantibodies and cognitive performance but they had a lot of clinical measures and didn't correct for multiple comparisons so have doubts if this is significant Higher antibodies were correlated with better performance. 1100
ME/CFS Science @mecfsscience.org · 15/05/20265) Some limitations of the study: the samples were not matched for age and sex (95% of ME/CFS was female compared to 77% in controls), they used the outdated Fukuda criteria (where PEM is not required) and medication use wasn't controlled for. 4120
